May 6, 2008 - VirtualScopics Inc. said today that its chief scientific officer, Edward Ashton, Ph.D., will deliver two speeches and co-author an abstract at the International Society for Magnetic Resonance Imaging in Medicine (ISMRM) conference in Toronto, Canada.

Ashton’s presentations on May 7 and 8 will focus on the company’s work in dynamic contrast-enhanced MRI, an advanced medical image analysis technique that measures blood flow and permeability and enables the early detection of a drug’s effectiveness in treating cancer and other diseases.

“Our proprietary analysis techniques surrounding the measuring of blood flow within a tumor continue to demonstrate great value to the industry,” Ashton said. “Because of the improved specificity and sensitivity of our tools we were able to determine that our method, compared to three other methods, was the only one that detected the treatment effect of our customer’s compound.”

For more information: www.virtualscopics.com


Related Content

News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Radiology Imaging

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...

Time August 21, 2026
arrow
News | Cardiac Imaging

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...

Time August 20, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
Subscribe Now